292 related articles for article (PubMed ID: 33350193)
1. [Systematic review and Meta-analysis on efficacy and safety of Buzhong Yiqi Decoction for stable chronic obstructive pulmonary disease].
Yi-Ling F; Qing M; Xing L; Chang-Zheng F; Mao-Rong F; Qing C; Ning W; Qiu-Xiao MA; Ya-Ni H
Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(22):5344-5355. PubMed ID: 33350193
[TBL] [Abstract][Full Text] [Related]
2. [Systematic review and Meta-analysis on efficacy and safety of Liujunzi Decoction combined with Western medicine for stable chronic obstructive pulmonary disease].
Yi-Ling F; Qing M; Xing L; Chang-Zheng F; Mao-Rong F; Qing C; Ning W; Qiu-Xiao MA; Ya-Ni H
Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(22):5331-5343. PubMed ID: 33350192
[TBL] [Abstract][Full Text] [Related]
3. A systematic review and meta-analysis of the herbal formula Buzhong Yiqi Tang for stable chronic obstructive pulmonary disease.
Chen Y; Shergis JL; Wu L; Yu X; Zeng Q; Xu Y; Guo X; Zhang AL; Xue CC; Lin L
Complement Ther Med; 2016 Dec; 29():94-108. PubMed ID: 27912964
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of Buzhong Yiqi decoction combined with western medicine in the treatment of myasthenia gravis: A protocol for systematic review and meta-analysis.
Zong G; Liu S; Chen Z; Hu Y
Medicine (Baltimore); 2021 Mar; 100(11):e24807. PubMed ID: 33725947
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of Buzhong Yiqi decoction combined with surgery for rectal prolapse: A protocol for systematic review and meta analysis.
Xie Y; Fan Y; Yang C; Wan R; Cheng X; Yang X; Hu Y; Deng C
Medicine (Baltimore); 2020 Oct; 99(41):e22732. PubMed ID: 33031344
[TBL] [Abstract][Full Text] [Related]
6. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
Keam SJ; Keating GM
Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
[TBL] [Abstract][Full Text] [Related]
7. [Systematically review of modified Sanzi Yangqin Decoction for treating acute exacerbation of chronic obstructive pulmonary disease].
Zheng WJ; Peng ZJ; Chen SW; Hong Y; Huang HT; Liao HL; Liu XH
Zhongguo Zhong Yao Za Zhi; 2019 May; 44(10):2171-2178. PubMed ID: 31355577
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy and safety of tiotropium Respimat in the treatment of chronic obstructive pulmonary disease: systematic review].
Cai HD; Hou J; Lyu YN; Xiong L; Lu MZ; Wu SL
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Aug; 40(8):596-603. PubMed ID: 28810313
[No Abstract] [Full Text] [Related]
9. [Meta-analysis and trial sequential analysis of modified Sangbaipi Decoction for treating acute exacerbation of chronic obstructive pulmonary disease].
Zheng WJ; Peng ZJ; Yan Q; Zhang CY; Liu BE; Hong Y; Liu XH
Zhongguo Zhong Yao Za Zhi; 2019 Sep; 44(17):3806-3815. PubMed ID: 31602957
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hospital-acquired pneumonia with multi-drug resistant organism by Buzhong Yiqi decoction based on Fuzheng Quxie classical prescription: study protocol for a randomized controlled trial.
Deng D; Chen Z; Jia L; Bu J; Ye M; Sun L; Gen Y; Zhang W; Chen G; Fang B
Trials; 2019 Dec; 20(1):817. PubMed ID: 31888702
[TBL] [Abstract][Full Text] [Related]
11. [Bronchodilator efficacy of combined salmeterol and tiotropium in patients with chronic obstructive pulmonary disease].
Baloira Villar A; Vilariño Pombo C
Arch Bronconeumol; 2005 Mar; 41(3):130-4. PubMed ID: 15766465
[TBL] [Abstract][Full Text] [Related]
12. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.
Farne HA; Cates CJ
Cochrane Database Syst Rev; 2015 Oct; (10):CD008989. PubMed ID: 26490945
[TBL] [Abstract][Full Text] [Related]
13. Tiotropium versus placebo for chronic obstructive pulmonary disease.
Karner C; Chong J; Poole P
Cochrane Database Syst Rev; 2012 Jul; (7):CD009285. PubMed ID: 22786525
[TBL] [Abstract][Full Text] [Related]
14. Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.
Welsh EJ; Cates CJ; Poole P
Cochrane Database Syst Rev; 2013 May; (5):CD007891. PubMed ID: 23728670
[TBL] [Abstract][Full Text] [Related]
15. Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in moderate COPD.
Rabe KF; Timmer W; Sagkriotis A; Viel K
Chest; 2008 Aug; 134(2):255-262. PubMed ID: 18403672
[TBL] [Abstract][Full Text] [Related]
16. [Network Meta-analysis of traditional Chinese medicine injections in treatment of chronic pulmonary heart disease].
Ban JF; Wang H; Wang ZX; Zhou YB; Qie R
Zhongguo Zhong Yao Za Zhi; 2024 May; 49(10):2798-2817. PubMed ID: 38812180
[TBL] [Abstract][Full Text] [Related]
17. Effects of Buzhong Yiqi Decoction Combined with THP Bladder Perfusion on Postoperative Efficacy in Patients with Bladder Cancer.
Wang Y; Zhang Y; Liu Z; Li Q; Jin H
Evid Based Complement Alternat Med; 2021; 2021():3685213. PubMed ID: 34804176
[TBL] [Abstract][Full Text] [Related]
18. Clinical Study on the Treatment of Female Stress Urinary Incontinence With Modified Buzhong Yiqi Decoction.
Zhou F; Chen C; Shi J; Zhou Q; Jin L; Ma X
Front Surg; 2022; 9():882621. PubMed ID: 35495748
[TBL] [Abstract][Full Text] [Related]
19. Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease.
Welsh EJ; Cates CJ; Poole P
Cochrane Database Syst Rev; 2010 May; (5):CD007891. PubMed ID: 20464758
[TBL] [Abstract][Full Text] [Related]
20. In Vitro, Pharmacokinetic, Pharmacodynamic, and Safety Comparisons of Single and Combined Administration of Tiotropium and Salmeterol in COPD Patients Using Different Dry Powder Inhalers.
Horhota ST; van Noord JA; Verkleij CB; Bour LJ; Sharma A; Trunk M; Cornelissen PJ
AAPS J; 2015 Jul; 17(4):871-80. PubMed ID: 25794622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
